Impact of Intraoperative ICG on Functional Outc in RARP

Summary

This is a pilot, 3 phases open-label feasibility study with the 3rd phase consisting of randomized 2-arm intervention trial, to assess the systematic use of indocyanine green (ICG) in subjects with prostate adenocarcinoma during robot-assisted radical prostatectomy and its impact on sexual function outcomes at 12 months postoperatively.

Timeline

Start

2024-07-12

Primary completion

2028-07

Completion

2030-07

Drugs

Indications